USPTO serial 79127685
BOEHRINGER INGELHEIM BIOXCELLENCE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 11, 2014
- Examiner
- DALIER, JOHN DAVID
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with BOEHRINGER INGELHEIM BIOXCELLENCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Boehringer Ingelheim Pharma; GmbH & Co. KG
DE
Other trademarks owned by Boehringer Ingelheim Pharma; GmbH & Co. KG
Boehringer Ingelheim Pharma; GmbH & Co. KG
DE
Other trademarks owned by Boehringer Ingelheim Pharma; GmbH & Co. KG
Boehringer Ingelheim Pharma GmbH & Co.KG
Ingelheim, DE
Other trademarks owned by Boehringer Ingelheim Pharma GmbH & Co.KG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Max Moskowitz
Max Moskowitz Ostrolenk Faber LLP845 THIRD AVENUE, 17th FloorNew York, NY 10022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biological products, substances and preparations for industrial and scientific purposes as well as for research purposes | ACTIVE | — |
| 005 | pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; preparations for destroying vermin; fungicides, herbicides; bacteriological cultures for medical and veterinary purposes as well as culture media for bacteriological cultures; bacteriological preparations for medical and veterinary use for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; biological preparations for medical and for veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; biochemical preparations for medical and veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; ferments for pharmaceutical purposes; vaccines; culture media for microorganisms; plasters and dressings for medical purposes | ACTIVE | — |
| 016 | Printed matter, namely, newspapers, photographs, magazines, books, printed periodicals, newsletters, and brochures all in the field of pharmaceutical preparations; paper; cardboard; goods made from paper and cardboard, namely, boxes of paper and cardboard boxes; cardboard packaging, namely, pharmaceutical packaging; patient record cards and prescription pads; in the field of in the fields of medicine and pharmaceuticals; printed teaching and instructional materials, namely, pharmaceutical information leaflets;books in the fields of medicine and pharmaceuticals; printed publications, namely, magazines, newsletters,pamphlets, reports, instructional and information leaflets, and posters in the fields of medicine and pharmaceuticals; paper packaging, namely, packaging containers of paper; stationery; printed instructional and teaching materials relating to the pharmaceutical, health care and medical fields, in the field of research, medicine, veterinary and laboratory techniques | ACTIVE | — |
| 035 | Compilation of data in computer databases, in particular in the field of biotechnology and biopharmaceutics; management in connection with the commercialization of technical or scientific results; management relating to the organisation of research; creation, namely, writing and compiling of manufacturing and registration dossiers for pharmaceutical products for third parties; office work, namely, operation of registration proceedings for pharmaceutical products | ACTIVE | — |
| 038 | [ Transmitting medical and scientific information by means of a database] | SECTION 71 - CANCELLED | — |
| 040 | Custom manufacture of pharmaceuticals, pharmaceutical ingredients, chemical products and chemical intermediates as well as of biological and biochemical products for third parties; treatment of biological materials, namely, batch treatment services with respect to microorganisms and proteins | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis and testing of active substances, medicine and treatment in the field of biotechnology; research and development of new products for other sand scientific laboratory services in the field of biotechnology; performance of chemical, biochemical and biological analysis; development of biological, biotechnological and pharmaceutical analysis and their application for others; technical and scientific consultancy, particularly in the field of biotechnology; scientific research; conducting clinical trials for others of pharmaceutical products; providing scientific information via the Internet in the field of pharmaceutical, health care and medical fields; scientific research consulting in the field of pharmaceutical, health care and medical fields | ACTIVE | — |
| 044 | Medical and veterinary consulting; providing medical and veterinary information via the Internet; all the aforementioned consultations and services also provided through a database; providing medical information via the Internet | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Boehringer Ingelheim Pharma; GmbH & Co. KG
- Other trademarks owned by Boehringer Ingelheim Pharma; GmbH & Co. KG
- Other trademarks owned by Boehringer Ingelheim Pharma GmbH & Co.KG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BOEHRINGER INGELHEIM BIOXCELLENCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 25, 2026 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Dec 7, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 7, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Apr 7, 2025 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 7, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 5, 2024 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Oct 7, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 16, 2024 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jul 16, 2024 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 14, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 11, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Sep 29, 2023 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 29, 2023 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| May 18, 2023 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Nov 26, 2022 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Nov 18, 2022 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Nov 17, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 17, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 17, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Nov 17, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 29, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 18, 2022 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Jan 21, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 12, 2020 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 11, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 24, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 3, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 3, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 11, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 11, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 2, 2014 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 17, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 17, 2014 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 26, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 26, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 6, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 6, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 6, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 23, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 23, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 22, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 22, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 22, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 23, 2014 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 23, 2014 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 23, 2014 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 21, 2014 | ZZAX | PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU | — |
| Jan 20, 2014 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 7, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 7, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 7, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 7, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 7, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 7, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 6, 2014 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 21, 2013 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 6, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 5, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 20, 2013 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Nov 20, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 12, 2013 | ALIE | ASSIGNED TO LIE | — |
| Nov 1, 2013 | ALIE | ASSIGNED TO LIE | — |
| Oct 31, 2013 | PAPER RECEIVED | — | |
| Oct 25, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 19, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 26, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 26, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 26, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 25, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2013 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Apr 20, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 19, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 15, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 15, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 11, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |